NUNC A/S
CVR: 39582910
Secondary names: Thermo Fisher Scientific A/S, Apogent Denmark A/S, Fisher Holdings A/S
NUNC A/S demonstrates strong financial health with a solid equity position of 2.47 billion DKK as of 2024, reflecting a significant increase from 800.62 million DKK in 2020. Revenue has stabilized around the 587 million DKK mark in 2023 and 2024, with a slight decline from 664.39 million DKK in 2022, while profit margins remain robust, hovering around 26% in recent years. The company has shown resilience in profitability, although the slight revenue decline may raise concerns about future growth. Overall, NUNC A/S holds a strong position within the plastics manufacturing industry, backed by consistent profits and a solid equity base.
AI-generated summary
Overview
Details
Contact
Purpose
Selskabets formål er at drive handel og fabrikation, herunder import- og eksportvirksomhed samt agentur
Location
Financials
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 587.5 mio. | 153.6 mio. | 2.6 mia. | 2.5 mia. | 370 | |
History
Ownership
Properties
(4)4 properties
Upgrade to Pro to see addresses, building data and ownership details
Management
Directors
Board
Production units (2)
Similar companies
Companies in the same industry and area